Wei Li (W Li)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 46

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

Cells

ACS pharmacology & translational science

The University of Tennessee Health Science Center

Columbia University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Tennessee Health Science Center Aug 05 2020

United States

UTHSC Distinguished Professor and Director of UTCoP Drug Discovery Center :: Pharmaceutical Sciences

University of Tennessee Health Science Center Jul 01 2014

United States

Professor and Faculty Director of Shared Instrument Facility :: Pharmaceutical Sciences

University of Tennessee Health Science Center Jul 01 2009 - Jun 30 2014

United States

Associate Professor :: Pharmaceutical Sciences

University of Tennessee Health Science Center Jul 01 2004 - Jun 30 2009

United States

Assistant Professor, tenure track :: Pharmaceutical Sciences

University of Tennessee Health Science Center Jul 01 2001 - Jun 30 2004

United States

Research Assistant Professor :: Pharmaceutical Sciences

University of Tennessee Health Science Center Aug 01 1999 - Jun 30 2001

United States

Instructor :: Pharmaceutical Sciences

Education History

Columbia University Aug 01 1994 - Jul 31 1999

United States

PHD :: Chemistry

Dalian Institute of Chemical Physics, Chinese Academy of Sciences Sep 01 1992 - May 31 1994

China

MSC :: State Key Laboratory of Molecular Dynamics

University of Science and Technology of China Sep 01 1987 - Jul 31 1992

China

BSC :: Chemistry

Publications

Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research (2024)
Shelby Waddell, Guannan Zhao, Ziping Liu, Hao Chen, Wenjing Zhang, Yaohong Wang, Duane D Miller, Junming Yue, Wei Li
VERU-111, an Orally Available Tubulin Inhibitor, Suppresses Ovarian Tumor Growth and Metastasis. The Journal of pharmacology and experimental therapeutics (2024)
Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy, Ewa Podgorska, S Gates Scott, Justyna Szpotan, Alisa A Mobley, Wei Li, Vijay K Boda, Senthilkumar Ravichandran, Robert Charles Tuckey, Anton M Jetten, Andrzej T Słominski
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 13 (3) (2024)
Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research 103 (9) (2024)
Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy, Ewa Podgorska, S Gates Scott, Justyna Szpotan, Alisa A Mobley, Wei Li, Vijay K Boda, Senthilkumar Ravichandran, Robert Charles Tuckey, Anton M Jetten, Andrzej T Słominski
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 13 (3) (2024)
Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research 103 (9) (2024)
Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy, Ewa Podgorska, S Gates Scott, Justyna Szpotan, Alisa A Mobley, Wei Li, Vijay K Boda, Senthilkumar Ravichandran, Robert Charles Tuckey, Anton M Jetten, Andrzej T Słominski
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 13 (3) (2024)
Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research 103 (9) (2024)
Vijay K Boda, Nelufar Yasmen, Jianxiong Jiang, Wei Li
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel. Medicinal research reviews (2024)
Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy, Ewa Podgorska, S Gates Scott, Justyna Szpotan, Alisa A Mobley, Wei Li, Vijay K Boda, Senthilkumar Ravichandran, Robert Charles Tuckey, Anton M Jetten, Andrzej T Słominski
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 13 (3) (2024)
Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy, Ewa Podgorska, S Gates Scott, Justyna Szpotan, Alisa A Mobley, Wei Li, Vijay K Boda, Senthilkumar Ravichandran, Robert Charles Tuckey, Anton M Jetten, Andrzej T Słominski
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 13 (3) (2024)
Vijay K Boda, Nelufar Yasmen, Jianxiong Jiang, Wei Li
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel. Medicinal research reviews (2024)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Najah Albadari, Wei Li
Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules (Basel, Switzerland) 28 (3) (2023)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Li Cao, Micholas Smith, Hanxuan Li, Wei Li, Jeremy Smith, Leigh Darryl Quarles, Zhousheng Xiao
Genetic interactions between Polycystin-1 and TAZ in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice. Research square (2023)
Najah Albadari, Wei Li
Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules (Basel, Switzerland) 28 (3) (2023)
Zhousheng Xiao, Li Cao, Micholas Dean Smith, Hanxuan Li, Wei Li, Jeremy C Smith, Leigh Darryl Quarles
Genetic interactions between polycystin-1 and Wwtr1 in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice. Bone research 11 (1) (2023)
Najah Albadari, Wei Li
Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules (Basel, Switzerland) 28 (3) (2023)
Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, Hao Chen, Deanna N Parke, Rui Wang, Sasha H Shafikhani, Dejian Ma, Pradeep B Lukka, Bernd Meibohm, Tiffany N Seagroves, Duane D Miller, Wei Li
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer. Molecular cancer therapeutics 21 (7) (2022)
Rajib Bhuniya, Xinrui Yuan, Longchuan Bai, Kathryn L Howie, Rui Wang, Wei Li, Frank Park, Chao-Yie Yang
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors. ACS medicinal chemistry letters 13 (2) (2022)
Raisa I Krutilina, Kelli L Hartman, Damilola Oluwalana, Hilaire C Playa, Deanna N Parke, Hao Chen, Duane D Miller, Wei Li, Tiffany N Seagroves
Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis. Cancers 14 (21) (2022)
Hanxuan Li, Mohamed Moustafa Ibrahim, Hao Chen, Wei Li, Monica M Jablonski
In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Linda K Myers, Michael Winstead, John D Kee, Jeoungeun J Park, Sicheng Zhang, Wei Li, Ae-Kyung Yi, John M Stuart, Edward F Rosloniec, David D Brand, Robert Charles Tuckey, Andrzej T Słominski, Arnold E Postlethwaite, Andrew H Kang
1,25-Dihydroxyvitamin D3 and 20-Hydroxyvitamin D3 Upregulate LAIR-1 and Attenuate Collagen Induced Arthritis. International journal of molecular sciences 22 (24) (2021)
Zhongzhi Wu, Lubing Gu, Sicheng Zhang, Tao Liu, Pradeep B Lukka, Bernd Meibohm, John C Bollinger, Muxiang Zhou, Wei Li
Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor. Journal of medicinal chemistry 64 (4) (2021)
Sicheng Zhang, Duane D Miller, Wei Li
Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System. International journal of molecular sciences 22 (4) (2021)
Monica L Brown Lobbins, Andrzej T Słominski, Karen A Hasty, Sicheng Zhang, Duane D Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Robert Charles Tuckey, Imara-Safi O Scott, Linda K Myers, Arnold E Postlethwaite
Modulation by 17,20S(OH) 2 pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis. International journal of molecular sciences 23 (1) (2021)
Monica L Brown Lobbins, Imara-Safi O Scott, Andrzej T Słominski, Karen A Hasty, Sicheng Zhang, Duane D Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Tejesh S Patel, Linda K Myers, Arnold E Postlethwaite
17,20S(OH)2pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model. International journal of molecular sciences 22 (16) (2021)
Souvik Banerjee, Foyez Mahmud, Shanshan Deng, Lingling Ma, Mi-Kyung Yun, Sayo O Fakayode, Kinsie E Arnst, Lei Yang, Hao Chen, Zhongzhi Wu, Pradeep B Lukka, Keyur Parmar, Bernd Meibohm, Stephen W White, Yu-Xi Wang, Wei Li, Duane D Miller
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. Journal of medicinal chemistry 64 (17) (2021)
Wen Shuai, Guan Wang, Yiwen Zhang, Faqian Bu, Sicheng Zhang, Duane D Miller, Wei Li, Liang Ouyang, Yu-Xi Wang
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy. Journal of medicinal chemistry 64 (12) (2021)
Hao Chen, Shanshan Deng, Najah Albadari, Mi-Kyung Yun, Sicheng Zhang, Yong Li, Dejian Ma, Deanna N Parke, Lei Yang, Tiffany N Seagroves, Stephen W White, Duane D Miller, Wei Li
Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents. Journal of medicinal chemistry 64 (16) (2021)
Kiran Kumar Reddi, Hanxuan Li, Wei Li, Sarada D Tetali
Berberine, A Phytoalkaloid, Inhibits Inflammatory Response Induced by LPS through NF-Kappaβ Pathway: Possible Involvement of the IKKα. Molecules (Basel, Switzerland) 26 (16) (2021)
Hao Chen, Shanshan Deng, Yuxi Wang, Najah Albadari, Gyanendra Kumar, Dejian Ma, Weimin Li, Stephen W White, Duane D Miller, Wei Li
Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties. Journal of medicinal chemistry 63 (2) (2020)
Shanshan Deng, Raisa I Krutilina, Qinghui Wang, Zongtao Lin, Deanna N Parke, Hilaire C Playa, Hao Chen, Duane D Miller, Tiffany N Seagroves, Wei Li
An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance. Molecular cancer therapeutics 19 (2) (2019)
Kinsie E Arnst, Yuxi Wang, Zi-Ning Lei, Dong-Jin Hwang, Gyanendra Kumar, Dejian Ma, Deanna N Parke, Qiang Chen, Jinliang Yang, Stephen W White, Tiffany N Seagroves, Zhe-Sheng Chen, Duane D Miller, Wei Li
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy. Molecular pharmacology 96 (1) (2019)
Kinsie E Arnst, Souvik Banerjee, Yuxi Wang, Hao Chen, Yong Li, Lei Yang, Weimin Li, Duane D Miller, Wei Li
X-ray Crystal Structure Guided Discovery and Antitumor Efficacy of Dihydroquinoxalinone as Potent Tubulin Polymerization Inhibitors. ACS chemical biology 14 (12) (2019)
Qinghui Wang, Kinsie E Arnst, Yuxi Wang, Gyanendra Kumar, Dejian Ma, Stephen W White, Duane D Miller, Weimin Li, Wei Li
Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin. Journal of medicinal chemistry 62 (14) (2019)
Jean Jacques Vanden Eynde, Arduino Aleksander Mangoni, Jarkko Rautio, Jérôme Leprince, Yasu-Taka Azuma, Alfonso T García-Sosa, Christopher Hulme, Josef Jampilek, Rafik Karaman, Wei Li, Paula A C Gomes, Dimitra Hadjipavlou-Litina, Raffaele Capasso, Athina Geronikaki, Gennaro Chiappetta, Jean Marc Sabatier, Rino Ragno, Tiziano Tuccinardi, Andrea Trabocchi, Jean-Yves Winum, Francisco Javier Luque, Katalin Prokai-Tatrai, Mariana Spetea, Michael Gütschow, Ivan Kosalec, Catherine Guillou, Maria Helena Vasconcelos, George Kokotos, Giulio Rastelli, Maria Emília Sousa, Clementina Manera, Sandra Gemma, Stefano Mangani, Carlo Siciliano, Stefania Galdieroa, Hong Liu, Peter J H Scott, Cristóbal de Los Ríos, Luigi A Agrofoglio, Simona Collina, Rita C Guedes, Diego Muñoz-Torrero
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6. Molecules (Basel, Switzerland) 25 (1) (2019)
Kinsie E Arnst, Souvik Banerjee, Hao Chen, Shanshan Deng, Dong-Jin Hwang, Wei Li, Duane D Miller
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy. Medicinal research reviews 39 (4) (2019)
Najah Albadari, Shanshan Deng, Wei Li
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert opinion on drug discovery 14 (7) (2019)
Guannan Zhao, Qinghui Wang, Zhongzhi Wu, Xinchun Tian, Huan Yan, Baojin Wang, Peixin Dong, Hidemichi Watari, Lawrence M Pfeffer, Yuqi Guo, Wei Li, Junming Yue
Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor. Molecular cancer therapeutics 18 (12) (2019)
Zongtao Lin, Srinivasa R Marepally, Emily S Y Goh, Chloe Y S Cheng, Zorica Janjetovic, Tae-Kang Kim, Duane D Miller, Arnold E Postlethwaite, Andrzej T Słominski, Robert C Tuckey, Carole Peluso-Iltis, Natacha Rochel, Wei Li
Investigation of 20S-hydroxyvitamin D3 analogs and their 1α-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities. Scientific reports 8 (1) (2018)
Souvik Banerjee, Kinsie E Arnst, Yuxi Wang, Gyanendra Kumar, Shanshan Deng, Lei Yang, Guo-Bo Li, Jinliang Yang, Stephen W White, Wei Li, Duane D Miller
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy. Journal of medicinal chemistry 61 (4) (2018)
Qinghui Wang, Kinsie E Arnst, Yuxi Wang, Gyanendra Kumar, Dejian Ma, Hao Chen, Zhongzhi Wu, Jinliang Yang, Stephen W White, Duane D Miller, Wei Li
Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities. Journal of medicinal chemistry 61 (17) (2018)

Wei Li.css-eqlu8i{font-size:small;padding-left:4px;} (W Li)

Publication Activity (10 Years)

Top Topics

Top Venues

Wei Li (W Li)